Pharmacovigilance is an activity aimed at the detection, identification, quantification, evaluation and prevention of possible risks derived from the use of medicines. Pharmacovigilance integrates an entire process of investigation, control and monitoring not only of effects caused by medications, through constant monitoring provided by the medical community, producing laboratories, pharmacists and people who have been trained in pharmacies, to provide support to the patient in this regard. An elementary factor is also the awareness of the general population, who, little by little, is integrating into the culture of reporting suspected adverse reactions caused by medications.

The main objectives of Pharmacovigilance are:

1- Early detection of adverse reactions and interactions unknown until that moment.

2-Detection of increases in the frequency of (known) adverse reactions.

3- Identification of risk factors and possible underlying mechanisms of adverse reactions.

4- Estimation of the quantitative aspects of the benefit/risk relationship and dissemination of the information necessary to improve the regulation and prescription of medicines.

This allows us to obtain global benefits or final objectives, of great importance for people's health and of primary value for health authorities such as:

1- The rational and safe use of medications.

2-The evaluation and communication of the risks and benefits of marketed medications.

3- Education and information to patients.

In order for these objectives to be met, it is necessary that notification exists, which is the main initiating factor of information.

For PROGELA, SA de CV, it is essential to achieve these objectives, which commits us to always develop reliable products of proven quality, as well as to monitor, record and report any information derived from possible adverse effects with which they may be related. our products.

PROGELA, SA de CV has implemented a Pharmacovigilance System that effectively allows the performance of this task, based on the regulations established by the Ministry of Health and the company's own principles.

To comply with the social responsibility we have to promote Pharmacovigilance, we invite our consumers and prescribing physicians to report any type of possible adverse event related to our products, ensuring that each of these will be followed up, since this information is very important. valuable which will be considered the answer to the trust of those who consume and prescribe our products.